Search

Your search keyword '"Hsiehchen, David"' showing total 278 results

Search Constraints

Start Over You searched for: Author "Hsiehchen, David" Remove constraint Author: "Hsiehchen, David"
278 results on '"Hsiehchen, David"'

Search Results

1. Tissue-specific thresholds of mutation burden associated with anti-PD-1/L1 therapy benefit and prognosis in microsatellite-stable cancers

2. The phosphatidylserine targeting antibody bavituximab plus pembrolizumab in unresectable hepatocellular carcinoma: a phase 2 trial

6. PBRM1 mutations might render a subtype of biliary tract cancers sensitive to drugs targeting the DNA damage repair system

8. Atezolizumab plus bevacizumab versus active surveillance in patients with resected or ablated high-risk hepatocellular carcinoma (IMbrave050): a randomised, open-label, multicentre, phase 3 trial

11. Efficacy and safety of immune checkpoint inhibitor rechallenge in individuals with hepatocellular carcinoma

13. Differences in systemic immune parameters in individuals with lung cancer according to race

16. Highly variable timing renders immunotherapy efficacy and toxicity impractical biomarkers of one another in clinical practice

21. pan-MHC and cross-Species Prediction of T Cell Receptor-Antigen Binding

22. Atezolizumab plus bevacizumab versus active surveillance in patients with resected or ablated high-risk hepatocellular carcinoma (IMbrave050): a randomised, open-label, multicentre, phase 3 trial

26. T-cell tolerant fraction as a predictor of immune-related adverse events

27. Disparities in Characteristics, Access to Care, and Oncologic Outcomes in Young-Onset Colorectal Cancer at a Safety-Net Hospital

40. Characteristics and clinical outcomes in young‐onset cholangiocarcinoma

41. Supplementary Table S2 from Devimistat in Combination with Gemcitabine and Cisplatin in Biliary Tract Cancer: Preclinical Evaluation and Phase Ib Multicenter Clinical Trial (BilT-04)

42. Data from Devimistat in Combination with Gemcitabine and Cisplatin in Biliary Tract Cancer: Preclinical Evaluation and Phase Ib Multicenter Clinical Trial (BilT-04)

43. Supplementary Figure S3 from Devimistat in Combination with Gemcitabine and Cisplatin in Biliary Tract Cancer: Preclinical Evaluation and Phase Ib Multicenter Clinical Trial (BilT-04)

46. Devimistat in combination with gemcitabine and cisplatin in biliary tract cancer: Pre-clinical evaluation and phase 1b multicenter clinical trial (BilT-04)

Catalog

Books, media, physical & digital resources